Last Updated On 11/6/2023 4:43:55 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: AstraZeneca |
| Recipient: You |
| Company: GOG Foundation |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Seagen |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: On Target Laboratories |
| Recipient: You |
| Company: Immunogen |
| Recipient: You |
| Company: Caris Life Sciences |
| Recipient: You |
|
| Speakers' Bureau |
| Company: Genmab/Seagen |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
|
| Research Funding |
| Company: Merck |
| Recipient: Your Institution |
| Company: Akeso Biopharma |
| Recipient: Your Institution |
| Company: GEICO |
| Recipient: Your Institution |
| Company: Karyopharm Therapeutics |
| Recipient: Your Institution |
| Company: GOG Foundation |
| Recipient: Your Institution |
| Company: Acrivon Therapeutics |
| Recipient: Your Institution |
| Company: Zentalis |
| Recipient: Your Institution |
| Company: Regeneron |
| Recipient: Your Institution |
| Company: Adaptimmune |
| Recipient: Your Institution |
| Company: Mersana |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: AstraZeneca |
| Recipient: You |
| Company: Seagen |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: GOG Foundation |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|